Abstract:Objective: To elucidate the molecular mechanisms involved in hypoxic preconditioning (HPC) of neonatal rat cardiomyocytes against hypoxia/reoxygenation (H/R) injury. Methods: Cardiomyocytes from neonatal Sprague–Dawley rats were randomly distributed into the following experimental groups: (1) HPC group: 20 min of hypoxia was performed to induce hypoxic preconditioning. Twenty four hours after HPC, cardiomyocytes were exposed to lethal hypoxia for 3 h followed by 3 h normoxia (reoxygenation). (2) Hypoxia/reoxygenation (H/R) group: cardiomyocytes were directly subjected to hypoxia (3 h) followed by reoxygenation (3 h). (3) PD98059+HPC (PD+HPC) group: cardiomyocytes were preincubated with PD98059 (a selective MEK-1/2 inhibitor, 50 μmol/l) 10 min prior to HPC. (4) BDM+HPC group: cardiomyocytes were pretreated with an activator of protein phosphatase 2,3-butanedione monoxide (BDM, 20 mmol/l) 10 min prior to HPC. (5) Control group: cardiomyocytes were incubated in cell incubator for 30 h. Viability of cardiomyocytes was assessed by MTT assay. Lactate dehydrogenase (LDH) activity in medium was determined using a LDH assay kit. Activity of p42/44 mitogen-activated protein kinases (p42/44 MAPKs) was detected using Western blotting method. SDS-PAGE mobility shift experiments were performed to determine phosphorylation of Hypoxia-inducible factor-1α (HIF-1α). Results: HPC promoted survival and membrane integrity of cardiomyocytes subjected to subsequent sustained H/R. The protective effects of HPC were completely abolished either by PD98059 [a selective inhibitor of MEK-1/2 (upstream activators of p42/44 MAPKs)], or by BDM (an activator of protein phosphatase). Western blot analysis showed activated p42/44 MAPKs in whole cell extracts from hypoxic preconditioned cardiomyocytes. SDS-PAGE mobility shift experiments showed increased phophorylation level of HIF-1α in HPC group, and the phosphorylation can be blocked by PD98059 or BDM. Conclusions: HPC protects neonatal cardiomyocytes against H/R injury by promoting cardiomyocyte survival and membrane integrity. The protective mechanism might be attributed to upregulation of HIF-1α phosphorylation which may be induced by P42/44 MAPKs.

Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cells

Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer Cells.

Dynamic regulation of mitochondrial pyruvate metabolism is necessary for orthotopic pancreatic tumor growth

Protein Kinase D1 Regulates Hypoxic Metabolism Through HIF-1α and Glycolytic Enzymes Incancer Cells.

Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms

Pyruvate dehydrogenase kinase 1 controls triacylglycerol hydrolysis in cardiomyocytes

Therapeutic Inhibition of Phospholipase D1 Suppresses Hepatocellular Carcinoma.

MAPK Signalling-Induced Phosphorylation and Subcellular Translocation of PDHE1α Promotes Tumour Immune Evasion.

Transcriptional Regulation of Pyruvate Dehydrogenase Kinase

Tissue-specific kinase expression and activity regulate flux through the pyruvate dehydrogenase complex

Dual-specificity Phosphatase DUSP1 Protects Overactivation of Hypoxia-Inducible Factor 1 Through Inactivating ERK MAPK.

PDHX acetylation facilitates tumor progression by disrupting PDC assembly and activating lactylation mediated gene expression

PAF1/HIF1α axis rewires the glycolytic metabolism to fuel aggressiveness of pancreatic cancer

Relation among Hypoxia,Diet,Exercise and PDC Regulation

Ptpmt1 Induced by HIF-2α Regulates the Proliferation and Glucose Metabolism in Erythroleukemia Cells.

Hypoxic preconditioning of cardiomyocytes and cardioprotection: phophorylation of HIF-1alpha induced by p42/p44 mitogen-activated protein kinases is involved.

ERK signaling controls productive HIF‐1 binding to chromatin and cancer cell adaptation to hypoxia through HIF‐1α interaction with NPM1

Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis

Hypoxia-induced downregulation of PGK1 crotonylation promotes tumorigenesis by coordinating glycolysis and the TCA cycle

Elucidating the kinetic and thermodynamic insight into regulation of glycolysis by lactate dehydrogenase and its impact on tricarboxylic acid cycle and oxidative phosphorylation in cancer cells

Glycolysis Gatekeeper PDK1 Reprograms Breast Cancer Stem Cells under Hypoxia